KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,826,127 | +2.3% | 11,868 | -15.5% | 0.00% | 0.0% |
| Q4 2022 | $2,763,607 | -32.8% | 14,052 | -21.8% | 0.00% | -50.0% |
| Q3 2022 | $4,110,000 | +222.1% | 17,973 | +71.6% | 0.00% | +100.0% |
| Q2 2022 | $1,276,000 | +1475.3% | 10,475 | +1431.4% | 0.00% | – |
| Q1 2021 | $81,000 | -69.2% | 684 | -72.0% | 0.00% | – |
| Q4 2020 | $263,000 | +345.8% | 2,447 | +234.7% | 0.00% | – |
| Q3 2020 | $59,000 | -51.2% | 731 | -41.0% | 0.00% | – |
| Q2 2020 | $121,000 | -68.3% | 1,240 | -75.6% | 0.00% | – |
| Q4 2019 | $382,000 | – | 5,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |